AIDS and HIV |
|
|
Clinical Trial: Housing and Health Study
This study is no longer recruiting patients.
|
Purpose
| Condition | Intervention |
|---|---|
| HIV AIDS | Procedure: Providing housing |
MedlinePlus related topics: AIDS
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Secondary Outcomes: Cost and cost effectiveness of the intervention; Proximal outcomes (e.g., increased condom use self-efficacy, social norms) associated with a reduction in HIV risk behaviors; Social contact, employment outcomes, quality of life, mental health
Expected Total Enrollment: 630
Study start: July 2004; Study completion: September 2007
Last follow-up: December 2006; Data entry closure: December 2006
Evidence is accumulating that homelessness and housing may be important factors that influence human immunodeficiency virus (HIV) sex and drug risk behaviors. Despite this apparent connection, few studies have investigated whether homelessness or unstable housing, compared with stable and adequate housing, is linked with HIV risk behaviors, and whether change in housing status is associated with change in risk behaviors.
The Housing and Health Study is a multi-site, multi-agency research collaboration. This project is a unique collaboration between federal agencies (the Department of Housing and Urban Development and the Centers for Disease Control and Prevention), local government agencies, universities, and private not-for-profit organizations.
The goal of the project is to examine the impact of providing housing for people living with HIV who are homeless or at imminent risk of homelessness on their disease progression, their risks of transmitting HIV, and medical care access and utilization. A total of 630 people living with HIV from three study sites complete the baseline study sessions. Half the participants (n=315) are randomly assigned to each of the two study groups. Treatment group participants receive Housing and Health Study housing rental assistance, and comparison group participants receive assistance finding housing according to local standard practice.
At baseline, 6, 12, and 18 months after baseline, participants complete study questionnaires and provide blood specimens to test for CD4 and viral load. In addition, the cost effectiveness of the study will be investigated by examining the HIV-related costs averted by providing housing to persons at high risk for transmitting HIV.
Eligibility
Inclusion Criteria:
- HIV seropositive
- At least 18 years of age
- English or Spanish speaking
- Able to provide informed consent
- Able to participate in data collection protocol
- Categorized as low income (less than 80% of the Area Median Income)
- Homeless or at imminent risk of homelessness
- Able to provide information about identity
Exclusion Criteria:
-
Location Information
Daniel P Kidder, PhD, Principal Investigator, Centers for Disease Control and Prevention
More Information
Last Updated: September 9, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00153504
Health Authority: United States: Centers for Disease Control and Prevention
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- AIDS and HIV (University of Maryland Medical Center)

Not Signed In -

